All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

312

Reset

312 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SugemalimabPhase 32 trials

    Akeso · NSCLC (Non-small Cell Lung Cancer), Extranodal NK/T-cell Lymphoma

  • TGRX-678Phase 32 trials

    Shenzhen TargetRx Co., Ltd. · Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia - Chronic Phase, Chronic Myeloid Leukemia

  • TQB2934Phase 32 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Multiple Myeloma, Systemic Light Chain Amyloidosis

  • TQB3473Phase 32 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Primary Immune Thrombocytopenia

  • TQB3909Phase 32 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Small Lymphocytic Lymppho, Relapsed/Refractory Chronic Lymphocytic Leukemia, Myeloid Malignancy

  • TR115Phase 32 trials

    Tarapeutics Science Inc. · Ovarian Clear Cell Carcinoma, Endometrial Cancer, Stomach Cancer Recurrent

  • Valoctocogene roxaparvovecBMN 270, GENEr8Phase 32 trials

    BioMarin · Hemophilia A, Hemophilia A With Inhibitor, Hemophilia A With Anti Factor VIII

  • VGA039Phase 32 trials

    Vega Therapeutics, Inc · Von Willebrand Diseases, Von Willebrand Disease (VWD)

  • ADX-2191Phase 31 trial

    Aldeyra Therapeutics, Inc. · Primary Vitreoretinal Lymphoma

  • AG-236Phase 31 trial

    Agios Pharmaceuticals, Inc. · Polycythemia Vera

  • ASTX030cedazuridine + azacitidinePhase 31 trial

    Taiho Oncology, Inc. · Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm

  • BCD-131pegdarbepoetin betaPhase 31 trial

    Biocad · Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis

  • ELVN-001Phase 31 trial

    Enliven Therapeutics · Chronic Myeloid Leukemia (CML), Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive, Chronic Phase Chronic Myeloid Leukemia, BCR::ABL1 Positive CML

  • Exa-celPhase 31 trial

    Vertex Pharmaceuticals · Sickle Cell Disease, Hematological Diseases, Hemoglobinopathies

  • FlumatinibPhase 31 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Myeloid Leukemia

  • FRSW117Recombinant human coagulation factor Ⅷ-Fc fusion proteinPhase 31 trial

    Hangzhou Gensciences Biopharmaceutical Co., Ltd. · Severe Hemophilia A

  • HLX15Phase 31 trial

    Shanghai Henlius Biotech · Newly Diagnosed Multiple Myeloma

  • HMPL-760Phase 31 trial

    Hutchmed · Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  • PF-06838435fidanacogene elaparvovecPhase 31 trial

    Pfizer · Hemophilia B

  • QTX-2101Phase 31 trial

    Quetzal Therapeutics · Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA

  • SKP-0141Phase 31 trial

    SK Plasma Co., Ltd. · Hemophilia A, Severe

  • STSP-0601Phase 31 trial

    Jiangsu BioJeTay Biotechnology Co., Ltd. · Hemophilia

  • TociluzumabPhase 31 trial

    Roche (Genentech) · Relapsed or Refractory Follicular Lymphoma

  • XY0206Phase 31 trial

    Shijiazhuang Yiling Pharmaceutical Co. Ltd · Acute Myeloid Leukemia With FLT3/ITD Mutation

  • BL-M08D1Phase 26 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Solid Tumors, Gastrointestinal Tumors, Diffuse Large B-Cell Lymphoma

  • EvorpaceptALX148Phase 25 trials

    ALX Oncology Inc. · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer, Metastatic

  • zamtocabtagene autoleucelMB-CART2019.1Phase 25 trials

    Miltenyi Biomedicine GmbH · CAR T Cell Therapy, Mantle Cell Lymphoma (MCL), Multiple Sclerosis

  • APG-115Phase 24 trials

    Ascentage Pharma Group Inc. · T-Prolymphocytic Leukemia, Non-Hodgkins Lymphoma, Liposarcoma

  • GecacitinibPhase 24 trials

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Lymphoma, Non-small Cell Lung Cancer, Advanced Solid Tumor

  • GNC-038Phase 24 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-hodgkin's Lymphoma, Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma

  • AZD4205Phase 23 trials

    Dizal Pharmaceuticals · Non-small Cell Lung Cancer, Peripheral T-cell Lymphoma, Peripheral T Cell Lymphoma

  • BudoprutugTNT119Phase 23 trials

    Climb Bio, Inc. · Primary Membranous Nephropathy, Systemic Lupus Erthematosus, Immune Thrombocytopenia (ITP)

  • CID-103Phase 23 trials

    CASI pharmaceuticals, Inc. · Chronic Immune Thrombocytopenia, Antibody Mediated Rejection

  • ESG206ESG206-2Phase 23 trials

    Shanghai Escugen Biotechnology Co., Ltd · Systemic Lupus Erythematosus (SLE), Immune Thrombocytopenia (ITP), Primary Sjögren Syndrome

  • IMR-687Tovinontrine, CRD-750Phase 23 trials

    Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases

  • Relma-celCAR, CD19-targeted Chimeric Antigen Receptor T CellsPhase 23 trials

    Shanghai Ming Ju Biotechnology Co., Ltd. · Non-Hodgkin Lymphoma, Large B-cell Lymphoma, Multiple Myeloma

  • RimiducidAP1903Phase 23 trials

    Bellicum Pharmaceuticals · Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Leukemia, Acute Myeloid (AML), Child

  • roginolisibIOA-244Phase 23 trials

    iOnctura · Myelofibrosis (MF), Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Advanced Non Squamous NSCLC

  • RVU120SEL120Phase 23 trials

    Ryvu Therapeutics SA · Advanced Solid Tumors, Acute Myeloid Leukaemia (AML), High-risk Myelodysplastic Syndrome

  • single CNCT19Phase 23 trials

    Juventas Cell Therapy Ltd. · Relapsed or Refractory Acute Lymphoblastic Leukemia, B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma

  • TulmimetostatDZR123, Tulmimetostat DL1Phase 23 trials

    Novartis · Progressive Metastatic Castrate Resistant Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Advanced Solid Tumor

  • valemetostat tosylateDS-3201bPhase 23 trials

    Daiichi Sankyo · Non-small Cell Lung Cancer, Lung Cancer, Relapsed/Refractory Peripheral T-Cell Lymphoma

  • Zugocabtagene geleucelCTX112Phase 23 trials

    CRISPR Therapeutics AG · B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy

  • AB-101zabalafinPhase 22 trials

    Alphyn Biologics · Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema, Atopic Dermatitis

  • AK129Phase 22 trials

    Akeso · Non-small Cell Lung Cancer Stage IIIB/IV, Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Adenocarcinoma

  • ALN-6400Phase 22 trials

    Alnylam Pharmaceuticals · Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB), Hereditary Hemorrhagic Telangiectasia

  • and oxaliplatinPhase 22 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma

  • and prednisonePhase 22 trials

    Genmab · Follicular Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma

  • AZD3470Phase 22 trials

    AstraZeneca · Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma

  • bexmarilimabFP-1305Phase 22 trials

    Faron Pharmaceuticals Ltd · Higher Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia

NewerPage 3 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.